Taiwan FDA registration b5035d06fac47b1a5d029dca35e34c40
"Linuofa" vagus nerve stimulation treatment system program controller
TW: “理諾珐”迷走神經刺激治療系統程控儀
Taiwan·Risk Class 3·LivaNova USA, Inc.·Registered Oct 24, 2023 – Oct 24, 2028ActiveRegistration details
- Analysis ID
- b5035d06fac47b1a5d029dca35e34c40
- Customs Code
- DHA05603650801
Company information
- Manufacturer
- LivaNova USA, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- K&C MEDICAL CO., LTD.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- K Neuroscience
- Product Type (Level 2)
- K.5820 植入式小腦刺激器
- Import Information
- import
Dates and status
- Registration Date
- Oct 24, 2023
- Expiry Date
- Oct 24, 2028
About this record
Access comprehensive regulatory information for "Linuofa" vagus nerve stimulation treatment system program controller in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number b5035d06fac47b1a5d029dca35e34c40 and manufactured by LivaNova USA, Inc.. The authorized representative in Taiwan is K&C MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices